Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 The future of NSCLC: molecular profiles guiding treatment decisions.

× No keyword cloud information.

4 in total

1. Clinical and epidemiological study of EGFR mutations and EML4-ALK fusion genes among Indian patients with adenocarcinoma of the lung.

Authors: Dc Doval; K Prabhash; S Patil; H Chaturvedi; C Goswami; Ak Vaid; S Desai; S Dutt; Vh Veldore; N Jambhekar; A Mehta; D Hazarika; S Azam; S Gawande; S Gupta
Journal: Onco Targets Ther Date: 2015-01-05 Impact factor: 4.147

2. Clinicopathological and molecular epidemiological study of lung cancer patients seen at a tertiary care hospital in Northern India.

Authors: Randeep Singh; Nitesh Rohtagi
Journal: South Asian J Cancer Date: 2017 Oct-Dec

3. Clinical outcome study of crizotinib in immunohistochemistry-proven echinoderm microtubule-associated protein-like 4-anaplastic lymphoma kinase fusion gene among Indian patients with adenocarcinoma lung.

Authors: Ullas Batra; Mohit Aggarwal; Parveen Jain; Pankaj Goyal; Abhishek Yadav; Udip Maheshwari; Anurag Mehta
Journal: South Asian J Cancer Date: 2018 Jan-Mar

4. Incidence of ROS1-Rearranged Non-Small-Cell Lung Carcinoma in India and Efficacy of Crizotinib in Lung Adenocarcinoma Patients.

Authors: Anurag Mehta; Mumtaz Saifi; Ullas Batra; M Suryavanshi; Kush Gupta
Journal: Lung Cancer (Auckl) Date: 2020-02-24

4 in total